Octaviant Financial

Precision Financing and Warranty Solutions for Transformational Therapies

The Problem

The Problem: The high-cost barrier to transformative therapy

Emerging treatments, such as gene and cell therapies, have the potential to cure diseases in as little as a single dose. However the upfront costs, compared to drugs administered regularly over time, will create a near-term financial strain on the healthcare system. And more importantly, this could limit patient access to treatments for rare diseases, genetic disorders, cancer and more.

Our Solution

The Solution: Increasing access to therapies through Octaviant Financial products and services

A specialized payment plan and warranty helps payers, providers, and biopharmaceutical companies manage the high upfront cost of innovative therapies. This will expand patient access to life-changing treatments while providing tremendous savings to the healthcare system in the long run.